Topspin Partners logo

Topspin Partners

North America, New York, United States, Mamaroneck

Description

Topspin is the successor fund to the Long Island Venture Fund, a successful venture capital fund which began investing in 1995.

Investor Profile

Topspin Partners has made 48 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (23%)
  • Series B (19%)
  • Series Unknown (15%)
  • Series D (10%)
  • Series A (10%)
  • Series E (8%)
  • Private Equity (6%)
  • Series F (4%)
  • Seed (2%)
  • Pre Seed (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Genetics
  • Biopharma
  • Manufacturing
  • Analytics
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Topspin Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
OrbiMed
North America, New York, United States, New York
Co-Investments: 8
RO
North America, California, United States, Oakland
Co-Investments: 3
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 3
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
NGEN Partners
North America, New York, United States, New York
Co-Investments: 3
The Column Group
North America, California, United States, San Francisco
Co-Investments: 11
TV
North America, Texas, United States, Dallas
Co-Investments: 3
Solon Mack Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Venrock
North America, California, United States, Palo Alto
Co-Investments: 3

Which angels does Topspin Partners often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1
EM
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Topspin Partners?

Mission Product Holdings

New York, New York, United States

Mission Product Holdings is a manufacturing firm that designs and provides wearable cooling solutions.

Consumer GoodsFashionProduct DesignRetailSporting GoodsSports
Private EquityJan 11, 2022
Coop Home Goods

Pico Rivera, California, United States

Coop offers adjustable sleep products.

CommercialConsumer GoodsWholesale
Private EquityAug 17, 2021
SportPet

Waukesha, Wisconsin, United States

SportPet is a seasoned manufacturer and marketer of branded and private label pet products.

ManufacturingPet
Private EquityAug 10, 2021
reCommerce

Florida, New York, United States

reCommerce is a full-service brand agency that assists international brands in optimizing their Amazon presence and increasing sales.

AdvertisingE-Commerce
Series UnknownMay 28, 2020
Codagenix

Farmingdale, New York, United States

Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.

BiotechnologyGeneticsMedical
Series BJan 13, 2020
Amount Raised: $20,000,000
PMV Pharmaceuticals

Redwood City, California, United States

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

BiopharmaBiotechnologyHealth CareMedical Device
Series CNov 13, 2019
Amount Raised: $62,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownSep 18, 2019
Amount Raised: $15,700,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series DAug 9, 2019
Amount Raised: $55,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series CJun 19, 2019
Amount Raised: $37,000,000
Celmatix

New York, New York, United States

Celmatix is a preclinical-stage biotech transforming women's lives through better ovarian health.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 1, 2019
Amount Raised: $6,500,000